cryptocurrency in, Knowledge graph

South Korea's unemployment rate in November was 2.7%, expected to be 2.7%, and the previous value was 2.70%.US Treasury Department: US Treasury Secretary Yellen expressed appreciation for the close communication between the Ministry of Economic Affairs of Korea and the United States after the recent events in South Korea.Market information: Nissan will appoint JÉRÉMIE PAPIN as the chief financial officer on Wednesday.

Nikkei futures opened down 95 points at 39,290 on the Singapore Stock Exchange.Goldman Sachs: I don't agree that gold can't reach $3,000 under a strong dollar. Goldman Sachs said that we don't agree with the view that the price of gold can't rise to $3,000 per ounce by the end of 2025 when the dollar remains strong for a long time. We predict that gold will reach $3,000 per ounce by the end of 2025, and the reduction of interest rate cuts by the Federal Reserve (rather than the strengthening of the US dollar) is the downside risk of this prediction.In November, the scale of wealth management exceeded expectations, and the scale of 14 wealth management companies increased by over 420 billion yuan. In November, the product scale of wealth management companies ushered in a general increase. According to the obtained data, in November, there were 6 state-owned wealth management companies and 8 joint-stock wealth management companies (CMB, Xingyin, Everbright, Xinyin, Ping 'an, Huaxia, Puyin and Minsheng), totaling 14 wealth management companies, with a survival scale of nearly 22.6 trillion yuan, an increase of more than 420 billion yuan compared with October, and the growth rate was slightly lower than the impact of capital backflow in October. (21st century business herald)

Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.South Korean Finance Minister and US Treasury Secretary Yellen confirmed that they will work closely together.The daily limit of the construction industry today is that CICC Fortune Beijing Jianguomenwai Street sold 455 million yuan, and the daily limit of the construction industry today was 2.004 billion yuan, with a turnover rate of 22.05%. After-hours data show that the special seats of Shenzhen Stock Connect bought 40.1869 million yuan and sold 19.4816 million yuan, CICC Fortune Beijing Jianguomenwai Street sold 455 million yuan and the special seats of one institution sold 26.1536 million yuan.